Author:
Ambassa Axel Cyriaque,Tiani Lionel Ulrich,Djuidje Ngounoue Marceline,Assam Assam Jean Paul,Andoseh Généviève,Kamdem Thiomo Diane,Tchinda Fossi Cédric,Nkah Numfor Leonard,Gonsu Kamga Hortense,kouanfack Charles,Pefura Yone Eric Walter,Ntoumi Francine,Penlap Beng Véronique
Subject
Agronomy and Crop Science,Genetics,Molecular Biology,Applied Microbiology and Biotechnology,Biotechnology
Reference43 articles.
1. Abrescia N, DAbbraccio M, Figoni M, Busto A, Butrico E, Marco MD, Viglietti R (2002). Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection. Journal Antimicrobial Chemotherapy 50(5):763-765.
2. Achonduh OA, AtoghoTB, Mbulli IA, Chedjou JP, Achu M, Nji AM, Fokou E, Kamgue E, Veyee V, Karana O, Sahfe D, Mbacham WF (2013). Adverse events clustering with NAT2 slow metabolisers following deparasitization in children in Bangolan, NWR Cameroon. Journal of Life Science 7(7):742-748.
3. An HR, Wu XQ, Wang ZY, Zhang JX, Liang Y (2012). NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients. Clinical and Experimental Pharmacology and Physiology 39(6):535-543.
4. Assam-Assam JP, Beng VP, Cho-Ngwa F, Tedom JC, Anyangwe AI, Titanji VPK (2011). Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Center regions of Cameroon. BMC Infectious Diseases 11(1):1-6.
5. Ben Mahmoud L, Ghozzi H, Kamoun A, Hakim A, Hachicha H, Hammami S, Sahoung Z, Zalila N, Makmih H, Zeghal K (2012). Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity 364 in Tunisian patients with tuberculosis. Pathologie Biologie 60(5):324-330.